FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200512834> ?p ?o ?g. }

• W4200512834 abstract "Abstract Background More than half of the adults with visual impairment experience severe symptoms of fatigue, with a negative impact on daily life. Since there is no evidence-based treatment to reduce fatigue in adults with visual impairment, we developed E-nergEYEze, an eHealth intervention based on cognitive behavioral therapy and self-management tailored to the needs of visually impaired adults. The aim is to describe the study protocol of a randomized controlled trial testing E-nergEYEze. Methods A randomized controlled trial will be conducted to investigate the cost-effectiveness and cost-utility of E-nergEYEze to reduce fatigue severity compared to care as usual from a healthcare and societal perspective. A total of 172 severely fatigued adults with visual impairment will be recruited and randomized to either the E-nergEYEze intervention plus care as usual or to care as usual only (ratio 1:1). Inclusion criteria are having a visual impairment, experiencing severe fatigue (Checklist Individual Strength – subscale Fatigue Severity: CIS-FS > 35), being 18 years or older, understanding the Dutch language, and having access to the internet. The intervention consists of one face-to-face session and a computer training followed by internet-based modules with information and assignments on coping with fatigue. During this 5-month intervention, participants will be digitally supported by a social worker. All measurements will be administered at baseline, after 6 and 12 months, and additionally, those related to cost-effectiveness at 3 and 9 months. The primary outcome is fatigue severity (CIS-FS). Discussion Severe fatigue on top of visual impairment compromises quality of life and is associated with incremental societal costs that largely determine the economic burden of low vision or blindness. E-nergEYEze contributes to the evidence base of potentially feasible interventions to reduce the important health-related consequences of vision loss and could fulfill the gap in knowledge, skills and treatment options for low vision services. Trial registration Dutch Trial Register NTR7764 . Registered on 28 May 2019." @default.
• W4200512834 created "2021-12-31" @default.
• W4200512834 creator A5010617508 @default.
• W4200512834 creator A5013574301 @default.
• W4200512834 creator A5018544138 @default.
• W4200512834 creator A5046383885 @default.
• W4200512834 creator A5051838792 @default.
• W4200512834 creator A5054017749 @default.
• W4200512834 creator A5055322466 @default.
• W4200512834 creator A5063951378 @default.
• W4200512834 creator A5076182692 @default.
• W4200512834 date "2021-12-01" @default.
• W4200512834 modified "2023-10-01" @default.
• W4200512834 title "E-nergEYEze, a vision-specific eHealth intervention based on cognitive behavioral therapy and self-management to reduce fatigue in adults with visual impairment: study protocol for a randomized controlled trial" @default.
• W4200512834 cites W1127081604 @default.
• W4200512834 cites W1873973516 @default.
• W4200512834 cites W1879055609 @default.
• W4200512834 cites W1900136306 @default.
• W4200512834 cites W1963774530 @default.
• W4200512834 cites W1970212100 @default.
• W4200512834 cites W1987138256 @default.
• W4200512834 cites W1996401369 @default.
• W4200512834 cites W2001462443 @default.
• W4200512834 cites W2016258952 @default.
• W4200512834 cites W2023604417 @default.
• W4200512834 cites W2029805433 @default.
• W4200512834 cites W2030894553 @default.
• W4200512834 cites W2031975127 @default.
• W4200512834 cites W2044091478 @default.
• W4200512834 cites W2051306513 @default.
• W4200512834 cites W2057454138 @default.
• W4200512834 cites W205950291 @default.
• W4200512834 cites W2060834289 @default.
• W4200512834 cites W2068642589 @default.
• W4200512834 cites W2089165963 @default.
• W4200512834 cites W2101131411 @default.
• W4200512834 cites W2101722234 @default.
• W4200512834 cites W2118502261 @default.
• W4200512834 cites W2119947320 @default.
• W4200512834 cites W2122274506 @default.
• W4200512834 cites W2122740969 @default.
• W4200512834 cites W2131657653 @default.
• W4200512834 cites W2134843796 @default.
• W4200512834 cites W2143715521 @default.
• W4200512834 cites W2144544687 @default.
• W4200512834 cites W2153459977 @default.
• W4200512834 cites W2161968952 @default.
• W4200512834 cites W2170059952 @default.
• W4200512834 cites W2179956378 @default.
• W4200512834 cites W2328538662 @default.
• W4200512834 cites W2607536539 @default.
• W4200512834 cites W2612027047 @default.
• W4200512834 cites W2617084495 @default.
• W4200512834 cites W2617720549 @default.
• W4200512834 cites W2620358687 @default.
• W4200512834 cites W2626691418 @default.
• W4200512834 cites W2741662223 @default.
• W4200512834 cites W2744294155 @default.
• W4200512834 cites W2752712485 @default.
• W4200512834 cites W2753080726 @default.
• W4200512834 cites W2769151522 @default.
• W4200512834 cites W2790285286 @default.
• W4200512834 cites W2796418735 @default.
• W4200512834 cites W2897711716 @default.
• W4200512834 cites W2982266214 @default.
• W4200512834 cites W2987557194 @default.
• W4200512834 cites W2999817131 @default.
• W4200512834 cites W3002102878 @default.
• W4200512834 cites W4229795691 @default.
• W4200512834 doi "https://doi.org/10.1186/s13063-021-05935-w" @default.
• W4200512834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34963472" @default.
• W4200512834 hasPublicationYear "2021" @default.
• W4200512834 type Work @default.
• W4200512834 citedByCount "2" @default.
• W4200512834 countsByYear W42005128342023 @default.
• W4200512834 crossrefType "journal-article" @default.
• W4200512834 hasAuthorship W4200512834A5010617508 @default.
• W4200512834 hasAuthorship W4200512834A5013574301 @default.
• W4200512834 hasAuthorship W4200512834A5018544138 @default.
• W4200512834 hasAuthorship W4200512834A5046383885 @default.
• W4200512834 hasAuthorship W4200512834A5051838792 @default.
• W4200512834 hasAuthorship W4200512834A5054017749 @default.
• W4200512834 hasAuthorship W4200512834A5055322466 @default.
• W4200512834 hasAuthorship W4200512834A5063951378 @default.
• W4200512834 hasAuthorship W4200512834A5076182692 @default.
• W4200512834 hasBestOaLocation W42005128341 @default.
• W4200512834 hasConcept C118552586 @default.
• W4200512834 hasConcept C141071460 @default.
• W4200512834 hasConcept C15744967 @default.
• W4200512834 hasConcept C160735492 @default.
• W4200512834 hasConcept C162324750 @default.
• W4200512834 hasConcept C168563851 @default.
• W4200512834 hasConcept C180747234 @default.
• W4200512834 hasConcept C1862650 @default.
• W4200512834 hasConcept C202645933 @default.
• W4200512834 hasConcept C2779356329 @default.
• W4200512834 hasConcept C2779891985 @default.
• W4200512834 hasConcept C2780665704 @default.
• W4200512834 hasConcept C2781265626 @default.
• W4200512834 hasConcept C2781372952 @default.

• next